IL-1 drives breast cancer growth and bone metastasis in vivo

BACKGROUND: We have recently identified interleukin 1B (IL-1B) as a potential biomarker for predicting breast cancer patients at increased risk for developing bone metastasis. In mouse models, IL-1B and its receptor (IL-1R1) are upregulated in breast cancer cells that metastasise to bone compared wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Holen, Ingunn, Lefley, Diane V., Francis, Sheila E., Rennicks, Sarah, Bradbury, Steven, Coleman, Robert E., Ottewell, Penelope
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342762/
https://www.ncbi.nlm.nih.gov/pubmed/27765923
http://dx.doi.org/10.18632/oncotarget.12289